CONTIGEN BARD COLLAGEN IMPLANT

FDA Premarket Approval P900030 S010

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for updated directions for use in order to strengthen information on adverse events.

DeviceCONTIGEN BARD COLLAGEN IMPLANT
Generic NameAgent, Bulking, Injectable For Gastro-urology Use
ApplicantAllergan, Inc.
Date Received2007-12-18
Decision Date2008-01-11
PMAP900030
SupplementS010
Product CodeLNM 
Advisory CommitteeGastroenterology/Urology
Supplement TypeSpecial (immediate Track)
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination Product No
Applicant Address Allergan, Inc. 71 South Los Carneros Road goleta, CA 93111

Supplemental Filings

Supplement NumberDateSupplement Type
P900030Original Filing
S011 2009-03-03 Normal 180 Day Track No User Fee
S010 2007-12-18 Special (immediate Track)
S009 2005-06-13 Normal 180 Day Track No User Fee
S008
S007
S006 1997-06-30 Real-time Process
S005 1995-11-01 Normal 180 Day Track
S004 1995-10-10 Normal 180 Day Track
S003 1994-11-17 Normal 180 Day Track
S002 1994-11-01 Normal 180 Day Track
S001 1993-11-15 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.